Skip to the page

Data / Drug companies / Grifols USA, LLC

Grifols USA, LLC: 21 products in the FDA NDC directory, labeler code 68516

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Grifols USA, LLC (labeler code 68516) lists 21 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 21 plasma derivatives. Its main marketing category is biologics (BLA). The newest product started marketing on November 15, 2023.

The request: Watch Grifols USA, LLC (FDA labeler code 68516): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
68516
Products in commercial distribution
21
Packages
30
Finished drugs by generic name
4
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
August 15, 1978
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Biologics (BLA)21100%

Products by type

TypeProductsShare
Plasma derivatives21100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Albumin (human)76
Coagulation factor ix (human)61
Antihemophilic factor/von willebrand factor complex (human)52
Factor ix complex31

Dosage forms

Dosage formProductsShare
Kit1466.7%
Injection, solution733.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

ClassProducts
Human Serum Albumin7

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Albutein68516-5218Injection, solutionBiologics (BLA)November 15, 2023
Albutein68516-5219Injection, solutionBiologics (BLA)November 9, 2023
Albutein68516-5216Injection, solutionBiologics (BLA)March 1, 2022
Albutein68516-5216Injection, solutionBiologics (BLA)March 1, 2022
Albutein68516-5215Injection, solutionBiologics (BLA)March 1, 2022
Albutein68516-5214Injection, solutionBiologics (BLA)March 1, 2022
Albutein68516-5215Injection, solutionBiologics (BLA)November 8, 2021
Alphanate68516-4620KitBiologics (BLA)June 26, 2014
AlphaNine SD68516-3612KitBiologics (BLA)December 31, 1990
AlphaNine SD68516-3611KitBiologics (BLA)December 31, 1990
AlphaNine SD68516-3610KitBiologics (BLA)December 31, 1990
AlphaNine SD68516-3609KitBiologics (BLA)December 31, 1990
AlphaNine SD68516-3608KitBiologics (BLA)December 31, 1990
AlphaNine SD68516-3607KitBiologics (BLA)December 31, 1990
Profilnine68516-3212KitBiologics (BLA)July 20, 1981
Profilnine68516-3211KitBiologics (BLA)July 20, 1981
Profilnine68516-3210KitBiologics (BLA)July 20, 1981
Alphanate68516-4619KitBiologics (BLA)August 15, 1978
Alphanate68516-4618KitBiologics (BLA)August 15, 1978
Alphanate68516-4617KitBiologics (BLA)August 15, 1978
Alphanate68516-4616KitBiologics (BLA)August 15, 1978

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.